In recent years, there has been increasingly extensive exploration of the function of Wnt/β-catenin in the initiation and progression of different cancers [46], and cyclin D1 and c-myc, which are downstream targets of Wnt/β-catenin signaling, have been shown to affect tumor proliferation and metastasis [46, 47]. Here, MYC is linked to cancer.